Citations (181)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (37)
Saif-El-Din El-Akkad, Seonaid Nolan, Kanna Hayashi, Huiru Dong, MJ Milloy, Kora Debeck & Lianping Ti. (2023) Factors associated with patient perceived suboptimal dosing of in-hospital opioid agonist therapy among people who use illicit drugs in Vancouver, Canada. Journal of Addictive Diseases 41:3, pages 204-212.
Read now
Read now
Bahram Armoon, Peter Higgs & Rasool Mohammadi. (2023) Mental health status, health service utilization, drug use behaviors associated with non-fatal overdose among people who use illicit drugs: A meta-analysis. Journal of Substance Use 28:2, pages 154-165.
Read now
Read now
Aaron R. Brown. (2022) Health professionals’ attitudes toward medications for opioid use disorder. Substance Abuse 43:1, pages 598-614.
Read now
Read now
William C. Bryson, Benjamin J. Morasco, Brandi P. Cotton & Stephen M. Thielke. (2021) Cannabis Use and Nonfatal Opioid Overdose among Patients Enrolled in Methadone Maintenance Treatment. Substance Use & Misuse 56:5, pages 697-703.
Read now
Read now
Michal Ordak, Tadeusz Nasierowski, Karolina Pawlik, Elzbieta Muszynska & Magdalena Bujalska-Zadrozny. (2020) Effectiveness of the methadone programme in the treatment of patients on a mephedrone binge and dependent on heroin: a retrospective study, 2010–19. International Journal of Psychiatry in Clinical Practice 24:3, pages 322-327.
Read now
Read now
John J. Mariani, Robert J. Malcolm, Agnieszka K. Mamczur, Jean C. Choi, Ronald Brady, Edward Nunes & Frances R. Levin. (2016) Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients. The American Journal of Drug and Alcohol Abuse 42:3, pages 333-340.
Read now
Read now
Jane Carlisle Maxwell. (2015) The Pain Reliever and Heroin Epidemic in the United States: Shifting Winds in the Perfect Storm. Journal of Addictive Diseases 34:2-3, pages 127-140.
Read now
Read now
Cheryl Teruya, Robert P. Schwartz$suffix/text()$suffix/text(), Shannon Gwin Mitchell, Albert L. Hasson$suffix/text()$suffix/text(), Christie Thomas, Samantha H. Buoncristiani$suffix/text()$suffix/text(), Yih-Ing Hser, Katharina Wiest, Allan J. Cohen, Naomi Glick, Petra Jacobs, Paul McLaughlin & Walter Ling. (2014) Patient Perspectives on Buprenorphine/Naloxone: A Qualitative Study of Retention During the Starting Treatment with Agonist Replacement Therapies (START) Study. Journal of Psychoactive Drugs 46:5, pages 412-426.
Read now
Read now
Nick Doukas. (2014) Are Methadone Counselors Properly Equipped to Meet the Palliative Care Needs of Older Adults in Methadone Maintenance Treatment? Implications for Training. Journal of Social Work in End-of-Life & Palliative Care 10:2, pages 186-204.
Read now
Read now
SML Van Den Broecke, EA De Letter, WE Lambert, AG Verstraete & MHA Piette. (2012) METHADONE-RELATED FATALITIES: REVIEW IN THE GHENT DISTRICT BETWEEN 1978-2008. Acta Clinica Belgica 67:5, pages 352-361.
Read now
Read now
Nick Doukas. (2011) Older Adults in Methadone Maintenance Treatment: A Literature Review. Journal of Social Work Practice in the Addictions 11:3, pages 230-244.
Read now
Read now
Michael Soyka, Henry R. Kranzler, Wim van den Brink, John Krystal, Hans-Jürgen Möller & Siegfried Kasper. (2011) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence. The World Journal of Biological Psychiatry 12:3, pages 160-187.
Read now
Read now
Alex Baldacchino & Sarah Walls. (2011) A comparison of accidental and intentional fatal drug overdoses within the drug death population in Scotland: a case of comortality?. Mental Health and Substance Use 4:1, pages 5-21.
Read now
Read now
Albert
Stuart Reece. (2010) Favorable Mortality Profile of Naltrexone Implants for Opiate Addiction. Journal of Addictive Diseases 29:1, pages 30-50.
Read now
Read now
Sheila M. Bird. (2010) Over 1200 drugs-related deaths and 190,000 opiate-user-years of follow-up: Relative risks by sex and age group. Addiction Research & Theory 18:2, pages 194-207.
Read now
Read now
Ingrid Davstad, Marlene Stenbacka, Anders Leifman & Anders Romelsjö. (2009) An 18-Year Follow-Up of Patients Admitted to Methadone Treatment for the First Time. Journal of Addictive Diseases 28:1, pages 39-52.
Read now
Read now
Michael Soyka & Christina Zingg. (2009) Feasability and safety of transfer from racemic methadone to (R)-methadone in primary care: Clinical results from an open study. The World Journal of Biological Psychiatry 10:3, pages 217-224.
Read now
Read now
Catherine S. Todd, Abdullah M.S. Abed, Paul T. Scott, Naqibullah Safi, Kenneth C. Earhart & Steffanie A. Strathdee. (2009) A Cross-Sectional Assessment of Utilization of Addiction Treatment among Injection Drug Users in Kabul, Afghanistan. Substance Use & Misuse 44:3, pages 416-430.
Read now
Read now
Louisa Degenhardt, Amy Gibson, Richard P. Mattick & Wayne Hall. (2008) Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy. Drug and Alcohol Review 27:1, pages 1-3.
Read now
Read now
Herbert D. Kleber. (2007) Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues in Clinical Neuroscience 9:4, pages 455-470.
Read now
Read now
Amy E. Gibson, Amy E. Gibson, Louisa J. Degenhardt, Amy E. Gibson & Louisa J. Degenhardt. (2007) Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records. Drug and Alcohol Review 26:4, pages 405-410.
Read now
Read now
Mark Latowsky. (2006) Methadone Death, Dosage and Torsade de Pointes: Risk-Benefit Policy Implications. Journal of Psychoactive Drugs 38:4, pages 513-519.
Read now
Read now
JohnW. Davison, MarieL. Sweeney, KristenR. Bush, TaniaM. Davis Correale, DonaldA. Calsyn, JosephP. Reoux, KevinL. Sloan & DanielR. Kivlahan. (2006) Outpatient Treatment Engagement and Abstinence Rates Following Inpatient Opioid Detoxification. Journal of Addictive Diseases 25:4, pages 27-35.
Read now
Read now
Anita Srivastava & Meldon Kahan. (2006) Methadone Induction Doses. Journal of Addictive Diseases 25:3, pages 5-13.
Read now
Read now
Benjamin Maas, Thomas Kerr, Nadia Fairbairn, Julio Montaner & Evan Wood. (2006) Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence. Expert Opinion on Drug Metabolism & Toxicology 2:4, pages 533-543.
Read now
Read now
Giedrius Vanagas, Zilvinas Padaiga & Eugenijus Bagdonas. (2006) Cost-Utility Analysis of Methadone Maintenance Treatment: A Methodological Approach. Substance Use & Misuse 41:1, pages 87-101.
Read now
Read now
Marc Auriacombe, Mélina Fatséas, Jacques Dubernet, Jean-Pierre Daulouède & Jean Tignol. (2004) French Field Experience with Buprenorphine. American Journal on Addictions 13:sup1, pages S17-S28.
Read now
Read now
Alison J Ritter. (2002) Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose. Australian and New Zealand Journal of Psychiatry 36:2, pages 224-228.
Read now
Read now
Cari L. Miller, Keith J. Chan, Anita Palepu, Mark Tyndall, Evan Wood, Robert Hogg & Michael V. O'shaughnessy. (2001) Socio-Demographic Profile and Hiv and Hepatitis C Prevalence Among Persons Who Died of a Drug Overdose. Addiction Research & Theory 9:5, pages 459-470.
Read now
Read now
Deborah Zador, Sandra Sunjic & James McLennan. (2001) Circumstances and Users' Perceptions of Heroin Overdose at the Time of the Event and at One-Week Follow-Up in Sydney, Australia: Implications for Prevention. Addiction Research & Theory 9:5, pages 407-423.
Read now
Read now
JohnR. M. Caplehorn. (2000) Knowledge of Methadone Toxicity Among US Maintenance Clinic Staff. Journal of Maintenance in the Addictions 1:4, pages 63-72.
Read now
Read now
DavidP. Desmond & JamesF. Maddux. (2000) Deaths Among Heroin Users in and out of Methadone Treatment. Journal of Maintenance in the Addictions 1:4, pages 45-61.
Read now
Read now
. (1999) Effective Medical Treatment of Opiate Addiction. Journal of Pharmaceutical Care in Pain & Symptom Control 7:3, pages 61-82.
Read now
Read now
John R.M. Caplehorn. (1998) Deaths in the first two weeks of maintenance treatment in NSW in 1994: Identifying cases of iatrogenic methadone toxicity. Drug and Alcohol Review 17:1, pages 9-17.
Read now
Read now
Helen Keane, John Caplehorn, Katherine M. Conigrave, Geoff Elvy & Andrew Byrne. (1998) Letters to the editor. Drug and Alcohol Review 17:2, pages 221-224.
Read now
Read now
John R. M. Caplehorn, Diana M. Hartel & Les Irwig. (1997) Measuring and Comparing the Attitudes and Beliefs of Staff Working in New York Methadone Maintenance Clinics. Substance Use & Misuse 32:4, pages 399-413.
Read now
Read now
John R. M. Caplehorn, Les Irwig & John B. Saunders. (1996) Physicians' Attitudes and Retention of Patients in Their Methadone Maintenance Programs. Substance Use & Misuse 31:6, pages 663-677.
Read now
Read now
Articles from other publishers (144)
Katja Troberg, Martin Bråbäck, Pernilla Isendahl, Suzan Nilsson, Disa Dahlman & Anders Håkansson. (2023) Malmö Treatment Referral and Intervention Study (MATRIS)—36-month follow-up on retention and substance use among patients referred from needle exchange to opioid agonist treatment—The role of stimulant use at baseline. Journal of Substance Use and Addiction Treatment 151, pages 209036.
Crossref
Crossref
Stefanie F. Gonçalves, Alyssa M. Izquierdo, Rebecca A. Bates, Angeela Acharya, Holly Matto & Siddhartha Sikdar. (2023) Negative Urgency Linked to Craving and Substance Use Among Adults on Buprenorphine or Methadone. The Journal of Behavioral Health Services & Research.
Crossref
Crossref
Eddy D. Barrera, Patrick D. Timken, Elaine Lee, Kirk R.S. Persaud, Hindy Goldstein, Daleya N. Parasram, Apoorva Vashisht & Robert Ranaldi. (2023) Environmental enrichment facilitates electric barrier induced heroin abstinence after incubation of craving in male and female rats. Drug and Alcohol Dependence 244, pages 109799.
Crossref
Crossref
Katja Troberg, Karin Lundqvist, Helena Hansson, Anders Håkansson & Disa Dahlman. (2022) Healthcare seeking among Swedish patients in opioid substitution treatment – a mixed methods study on barriers and facilitators. Substance Abuse Treatment, Prevention, and Policy 17:1.
Crossref
Crossref
John R. Brooklyn & Dwight E. Matthews. (2022) Simple, Rapid Spectrophotometric Assay of Dispensed Methadone for Diversion Control. Journal of Addiction Medicine 16:6, pages 671-677.
Crossref
Crossref
Suzanne Nielsen, Wai Chung Tse & Briony Larance. (2022) Opioid agonist treatment for people who are dependent on pharmaceutical opioids. Cochrane Database of Systematic Reviews 2022:9.
Crossref
Crossref
Michael Soyka. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
494
509
.
Amber N. Edinoff, Catherine A. Nix, Claudia V. Orellana, Samantha M. StPierre, Erin A. Crane, Blaine T. Bulloch, Elyse M. Cornett, Rachel L. Kozinn, Adam M. Kaye, Kevin S. Murnane & Alan D. Kaye. (2021) Naltrexone Implant for Opioid Use Disorder. Neurology International 14:1, pages 49-61.
Crossref
Crossref
Michael Soyka. (2021) Missbrauch und Abhängigkeit von Benzodiazepinen und Z-Drugs. Nervenheilkunde 40:08, pages 636-647.
Crossref
Crossref
Stefano Errico, Davide Bedocchi, Martina Drommi, Rosario Barranco, Alessandro Bonsignore & Francesco Ventura. (2021) Forensic pathological study of methadone-related deaths in the Genoa (Italy) district: A six-year study. Journal of Forensic and Legal Medicine 79, pages 102149.
Crossref
Crossref
Andrew Scheibe, Shaun Shelly, Tara Gerardy, Zara von Homeyer, Andrea Schneider, Kalvanya Padayachee, Shalon Balaguru Naidoo, Klaas Mtshweni, Ayanda Matau, Harry Hausler & Monique Marks. (2020) Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa. Addiction Science & Clinical Practice 15:1.
Crossref
Crossref
Anees Bahji, Breagh Cheng, Samantha Gray & Heather Stuart. (2020) Mortality Among People With Opioid Use Disorder: A Systematic Review and Meta-analysis. Journal of Addiction Medicine 14:4, pages e118-e132.
Crossref
Crossref
Charles DeShazer, Oralia Dominic, Caesar DeLeo & Rhonda Johnson. (2020) Impact of a Health System's Three-Pronged Strategy to Address the Opioid Epidemic in DE, PA, and WV, 2013-2017. The Open Public Health Journal 13:1, pages 152-160.
Crossref
Crossref
Mahip Acharya, Divyan Chopra, Corey J. Hayes, Benjamin Teeter & Bradley C. Martin. (2020) Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users. Value in Health 23:4, pages 451-460.
Crossref
Crossref
Jun Ma, Yan-Ping Bao, Ru-Jia Wang, Meng-Fan Su, Mo-Xuan Liu, Jin-Qiao Li, Louisa Degenhardt, Michael Farrell, Frederic C. Blow, Mark Ilgen, Jie Shi & Lin Lu. (2018) Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Molecular Psychiatry 24:12, pages 1868-1883.
Crossref
Crossref
Alyse M. Reichheld, Kelsey Hills-Evans, Julia K. Sheehan, Noah X. Tocci, Mudit Tandon, Douglas Hsu, John Marshall, Sharon O'Donoghue & Jennifer P. Stevens. (2019) A national survey of approaches to manage the ICU patient with opioid use disorder. Journal of Critical Care 54, pages 42-47.
Crossref
Crossref
A. Bahji, B. Cheng, S. Gray & H. Stuart. (2019) Reduction in mortality risk with opioid agonist therapy: a systematic review and meta‐analysis. Acta Psychiatrica Scandinavica 140:4, pages 313-339.
Crossref
Crossref
Courtney Pearson Jeske & Patrick O’Byrne. (2019) Perceptions and Experiences of Methadone Maintenance Treatment. Journal of Addictions Nursing 30:4, pages 248-253.
Crossref
Crossref
Matisyahu Shulman, Jonathan M. Wai & Edward V. Nunes. (2019) Buprenorphine Treatment for Opioid Use Disorder: An Overview. CNS Drugs 33:6, pages 567-580.
Crossref
Crossref
Katja Troberg, Anders Håkansson & Disa Dahlman. (2019) Self-Rated Physical Health and Unmet Healthcare Needs among Swedish Patients in Opioid Substitution Treatment. Journal of Addiction 2019, pages 1-10.
Crossref
Crossref
Barbara Lovrecic, Mercedes Lovrecic, Branko Gabrovec, Marco Carli, Matteo Pacini, Angelo G. I. Maremmani & Icro Maremmani. (2019) Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health. International Journal of Environmental Research and Public Health 16:2, pages 177.
Crossref
Crossref
Colin D Steer, John Macleod, Kate Tilling, Aaron G Lim, John Marsden, Tim Millar, John Strang, Maggie Telfer, Heather Whitaker, Peter Vickerman & Matthew Hickman. (2019) The impact of opiate substitution treatment on mortality risk in drug addicts: a natural experiment study. Health Services and Delivery Research 7:3, pages 1-92.
Crossref
Crossref
Annie Madden. (2018)
Commentary on Madden
et al
. (2018): ‘It's not only about the destination… it's also about the journey!’ Consumer perspectives on a model of open-access MAT provision
. Addiction 113:8, pages 1459-1460.
Crossref
Crossref
Phillip L. Marotta & Charlotte A. McCullagh. (2017) A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013. European Journal of Epidemiology 33:7, pages 679-688.
Crossref
Crossref
Milad Parpouchi, Akm Moniruzzaman, Stefanie N. Rezansoff, Angela Russolillo & Julian M. Somers. (2018) The effect of Housing First on adherence to methadone maintenance treatment. International Journal of Drug Policy 56, pages 73-80.
Crossref
Crossref
Andrea Shashoua. 2018. Challenging Cases and Complication Management in Pain Medicine. Challenging Cases and Complication Management in Pain Medicine
27
30
.
Kai-Chiang Yu, Han-Ting Wei, Yuh-Hsiang Yeh & Chung-Hua Hsu. (2017) Traditional Chinese medicine-facilitated treatments may relieve anxiety symptoms during drug switching from methadone to buprenorphine/naloxone for treating opioid dependence. BMJ Case Reports, pages bcr-2017-220815.
Crossref
Crossref
Corey S. Davis & Derek H. Carr. (2017) The Law and Policy of Opioids for Pain Management, Addiction Treatment, and Overdose Reversal. Indiana Health Law Review 14:1, pages 1.
Crossref
Crossref
Martin Bråbäck, Lars Ekström, Katja Troberg, Suzan Nilsson, Pernilla Isendahl, Louise Brådvik & Anders Håkansson. (2017) Malmö Treatment Referral and Intervention Study—High 12-Month Retention Rates in Patients Referred from Syringe Exchange to Methadone or Buprenorphine/Naloxone Treatment. Frontiers in Psychiatry 8.
Crossref
Crossref
Leo Beletsky & Corey S. Davis. (2017) Today’s fentanyl crisis: Prohibition’s Iron Law, revisited. International Journal of Drug Policy 46, pages 156-159.
Crossref
Crossref
Anjalee Sharma, Sharon M. Kelly, Shannon Gwin Mitchell, Jan Gryczynski, Kevin E. O’Grady & Robert P. Schwartz. (2017) Update on Barriers to Pharmacotherapy for Opioid Use Disorders. Current Psychiatry Reports 19:6.
Crossref
Crossref
Jonathan M. Davis, Katie Suleta, Karen F. Corsi & Robert E. Booth. (2017) A Hazard Analysis of Risk Factors of Mortality in Individuals Who Inject Drugs in Denver CO. AIDS and Behavior 21:4, pages 1044-1053.
Crossref
Crossref
Robert P. Schwartz, Sharon M. Kelly, Shannon G. Mitchell, Jan Gryczynski, Kevin E. O'Grady, Devang Gandhi, Yngvild Olsen & Jerome H. Jaffe. (2017) Patient-centered methadone treatment: a randomized clinical trial. Addiction 112:3, pages 454-464.
Crossref
Crossref
Anders Ledberg. (2017) Mortality related to methadone maintenance treatment in Stockholm, Sweden, during 2006–2013. Journal of Substance Abuse Treatment 74, pages 35-41.
Crossref
Crossref
Andrew Deonarine, Ashraf Amlani, Graham Ambrose & Jane A. Buxton. (2016) Qualitative assessment of take-home naloxone program participant and law enforcement interactions in British Columbia. Harm Reduction Journal 13:1.
Crossref
Crossref
Stefan Gutwinski, Nikola Schoofs, Heiner Stuke, Thomas G. Riemer, Corinde E. Wiers & Felix Bermpohl. (2016) Opioid tolerance in methadone maintenance treatment: comparison of methadone and levomethadone in long-term treatment. Harm Reduction Journal 13:1.
Crossref
Crossref
Jeremy Mayer, Timothy Mayer, Bonnie Stabile, Kathleen Kane-Willis, Scott Metzger, Katharine A. Neill & James Swartz. (2016) Medical System Rant and Response: Perspective of a Substance Abuse Counselor. World Medical & Health Policy 8:3, pages 344-353.
Crossref
Crossref
Suzanne Nielsen, Briony Larance, Louisa Degenhardt, Linda Gowing, Chyanne Kehler & Nicholas Lintzeris. (2016) Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Martin Bråbäck, Suzan Nilsson, Pernilla Isendahl, Katja Troberg, Louise Brådvik & Anders Håkansson. (2016) Malmö Treatment Referral and Intervention Study (MATRIS)-effective referral from syringe exchange to treatment for heroin dependence: a pilot randomized controlled trial. Addiction 111:5, pages 866-873.
Crossref
Crossref
Elizabeth A. Samuels, Kristin Dwyer, Michael J. Mello, Janette Baird, Adam R. Kellogg & Edward Bernstein. (2016) Emergency Department-based Opioid Harm Reduction: Moving Physicians From Willing to Doing. Academic Emergency Medicine 23:4, pages 455-465.
Crossref
Crossref
Philip Todd Korthuis, Kathleen A. McGinnis, Kevin L. Kraemer, Adam J. Gordon, Melissa Skanderson, Amy C. Justice, Stephen Crystal, Matthew Bidwell Goetz, Cynthia L. Gibert, David Rimland, Lynn E. Fiellin, Julie R. Gaither, Karen Wang, Steven M. Asch, Donald Keith McInnes, Michael E. Ohl, Kendall Bryant, Janet P. Tate, Mona Duggal & David A. Fiellin. (2016) Quality of HIV Care and Mortality Rates in HIV-Infected Patients. Clinical Infectious Diseases 62:2, pages 233-239.
Crossref
Crossref
Stephanie Lake, Kanna Hayashi, Jane Buxton, M.-J. Milloy, Huiru Dong, Evan Wood, Julio Montaner & Thomas Kerr. (2015) The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. Drug and Alcohol Dependence 156, pages 297-303.
Crossref
Crossref
Elizabeth Evans, Libo Li, Jeong Min, David Huang, Darren Urada, Lei Liu, Yih-Ing Hser & Bohdan Nosyk. (2015) Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10. Addiction 110:6, pages 996-1005.
Crossref
Crossref
Kellie M. Jaremko, Robert C. Sterling & Elisabeth J. Van Bockstaele. (2015) Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenance. Journal of Substance Abuse Treatment 48:1, pages 117-127.
Crossref
Crossref
Dagmar Hedrich & Richard Hartnoll. 2015. Textbook of Addiction Treatment: International Perspectives. Textbook of Addiction Treatment: International Perspectives
1291
1313
.
Timothy W. Lineberry & Kathleen T. Brady. 2014. A Concise Guide to Understanding Suicide. A Concise Guide to Understanding Suicide
117
122
.
. 2014. A Concise Guide to Understanding Suicide. A Concise Guide to Understanding Suicide
87
138
.
D. Tzemis, D. Al-Qutub, A. Amlani, S. Kesselring & J. A. Buxton. (2014) A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program. CMAJ Open 2:3, pages E153-E161.
Crossref
Crossref
Suzanne Nielsen, Louisa Degenhardt, Briony Larance, Linda Gowing, Chyanne Kehler & Nicholas Lintzeris. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Melissa B. Weimer & Roger Chou. (2014) Research Gaps on Methadone Harms and Comparative Harms: Findings From a Review of the Evidence for an American Pain Society and College on Problems of Drug Dependence Clinical Practice Guideline. The Journal of Pain 15:4, pages 366-376.
Crossref
Crossref
Roger Chou, Melissa B. Weimer & Tracy Dana. (2014) Methadone Overdose and Cardiac Arrhythmia Potential: Findings From a Review of the Evidence for an American Pain Society and College on Problems of Drug Dependence Clinical Practice Guideline. The Journal of Pain 15:4, pages 338-365.
Crossref
Crossref
Ivar Skeie, Thomas Clausen & Anne Bukten. (2014) Legemiddelassistert rehabilitering – viktig behandling med dilemmaer. Tidsskrift for Den norske legeforening 134:11, pages 1156-1158.
Crossref
Crossref
Helge Waal & Michael Gossop. (2014) Making Sense of Differing Overdose Mortality: Contributions to Improved Understanding of European Patterns. European Addiction Research 20:1, pages 8-15.
Crossref
Crossref
Pier Paolo Pani, Emanuela Trogu, Icro Maremmani & Matteo Pacini. (2013) QTc interval screening for cardiac risk in methadone treatment of opioid dependence. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Robert P. SchwartzJan GryczynskiKevin E. O’GradyJoshua M. SharfsteinGregory WarrenYngvild OlsenShannon G. MitchellJerome H. Jaffe. (2013) Opioid Agonist Treatments and Heroin Overdose Deaths in Baltimore, Maryland, 1995–2009. American Journal of Public Health 103:5, pages 917-922.
Crossref
Crossref
Ross M. Colquhoun. (2013) Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone. Substance Abuse: Research and Treatment 7, pages SART.S10776.
Crossref
Crossref
Ayman Fareed. 2013. Interventions for Addiction. Interventions for Addiction
407
416
.
Erin Kelty & Gary Hulse. (2012) Examination of mortality rates in a retrospective cohort of patients treated with oral or implant naltrexone for problematic opiate use. Addiction 107:10, pages 1817-1824.
Crossref
Crossref
AR Lingford-Hughes, S Welch, L Peters & DJ Nutt. (2012) BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. Journal of Psychopharmacology 26:7, pages 899-952.
Crossref
Crossref
Donald G. Barceloux. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse
579
602
.
Warren Harlow, Brenda Happell & Graeme Browne. (2011) Opioid replacement therapy: A wait unmanaged. International Journal of Mental Health Nursing 20:6, pages 418-427.
Crossref
Crossref
Luis Jimenez-Treviño, Pilar A. Saiz, M. Paz García-Portilla, Eva M. Díaz-Mesa, Fernando Sánchez-Lasheras, Patricia Burón, M. José Casares, Pedro Marina, Eduardo Gutiérrez(†)Julio Bobes. (2011) A 25-year follow-up of patients admitted to methadone treatment for the first time: Mortality and gender differences. Addictive Behaviors 36:12, pages 1184-1190.
Crossref
Crossref
Gráinne Cousins, Conor Teljeur, Nicola Motterlini, Colin McCowan, Borislav D. Dimitrov & Tom Fahey. (2011) Risk of drug-related mortality during periods of transition in methadone maintenance treatment: A cohort study. Journal of Substance Abuse Treatment 41:3, pages 252-260.
Crossref
Crossref
Melissa B. Weimer, P. Todd Korthuis, George S. Behonick & Martha J. Wunsch. (2011) The Source of Methadone in Overdose Deaths in Western Virginia in 2004. Journal of Addiction Medicine 5:3, pages 188-202.
Crossref
Crossref
Traci C. Green, Nickolas Zaller, Josiah Rich, Sarah Bowman & Peter Friedmann. (2011) Revisiting Paulozzi et al.'s “Prescription Drug Monitoring Programs and Death Rates from Drug Overdose”: Table 1. Pain Medicine 12:6, pages 982-985.
Crossref
Crossref
Michelle E. Madden & Steven L. Shapiro. (2011) The Methadone Epidemic. American Journal of Forensic Medicine & Pathology 32:2, pages 131-135.
Crossref
Crossref
Donna M. Coviello, Dave A. Zanis, Susan A. Wesnoski, Kevin G. Lynch & Michelle Drapkin. (2011) Characteristics and 9-month outcomes of discharged methadone maintenance clients. Journal of Substance Abuse Treatment 40:2, pages 165-174.
Crossref
Crossref
A. FareedS. StoutJ. CasarellaS. VayalapalliJ. CoxK. Drexler. (2011) Illicit Opioid Intoxication: Diagnosis and Treatment. Substance Abuse: Research and Treatment 5, pages SART.S7090.
Crossref
Crossref
John Macleod, Lorraine Copeland, Matthew Hickman, James McKenzie, Jo Kimber, Daniela De Angelis & James R Robertson. (2010) The Edinburgh Addiction Cohort: recruitment and follow-up of a primary care based sample of injection drug users and non drug-injecting controls. BMC Public Health 10:1.
Crossref
Crossref
Christine Yuodelis‐Flores, W. Murray Bennett, Charles Meredith & Richard Ries. 2010. Addictive Disorders in Medical Populations. Addictive Disorders in Medical Populations
197
218
.
Gez Bevan. (2009) Problem drug use the public health imperative: what some of the literature says. Substance Abuse Treatment, Prevention, and Policy 4:1.
Crossref
Crossref
Albert Stuart Reece. (2009) Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine. Journal of Substance Abuse Treatment 37:3, pages 256-265.
Crossref
Crossref
MARK A. STOOVÉ, PAUL M. DIETZE & DAMIEN JOLLEY. (2009) Overdose deaths following previous non-fatal heroin overdose: Record linkage of ambulance attendance and death registry data. Drug and Alcohol Review 28:4, pages 347-352.
Crossref
Crossref
Thomas Clausen, Ingrid Havnes & Helge Waal. (2009) Overdosestatistikk – et komplisert regnskap. Tidsskrift for Den norske legeforening 129:21, pages 2233-2236.
Crossref
Crossref
Perihan Torun, Richard F. Heller & Arpana Verma. (2009) Potential population impact of changes in heroin treatment and smoking prevalence rates: using Population Impact Measures. European Journal of Public Health 19:1, pages 28-31.
Crossref
Crossref
Suzanne Nielsen, Paul Dietze, Kate Cantwell, Nicole Lee & David Taylor. (2008) Methadone- and buprenorphine-related ambulance attendances: A population-based indicator of adverse events. Journal of Substance Abuse Treatment 35:4, pages 457-461.
Crossref
Crossref
Robert James Tait, Hanh Thi Thu Ngo & Gary Kenneth Hulse. (2008) Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment. Journal of Substance Abuse Treatment 35:2, pages 116-124.
Crossref
Crossref
Michael Soyka, Christina Zingg, Gabriele Koller & Heinrich Kuefner. (2008) Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study. The International Journal of Neuropsychopharmacology 11:05.
Crossref
Crossref
Mark A. Stoové, Paul M. Dietze, Campbell K. Aitken & Damien Jolley. (2008) Mortality among injecting drug users in Melbourne: A 16-year follow-up of the Victorian Injecting Cohort Study (VICS). Drug and Alcohol Dependence 96:3, pages 281-285.
Crossref
Crossref
Thomas Clausen, Katinka Anchersen & Helge Waal. (2008) Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study. Drug and Alcohol Dependence 94:1-3, pages 151-157.
Crossref
Crossref
Leslie L. Buckley, Nicholas Seivewright, Mark Parry, Abhijeetha Salvaji & Richard Schottenfeld. 2010. Cambridge Textbook of Effective Treatments in Psychiatry. Cambridge Textbook of Effective Treatments in Psychiatry
381
401
.
George E. Woody, Vince Kane, Kimberly Lewis & Richard Thompson. (2007) Premature Deaths After Discharge from Methadone Maintenance: A Replication. Journal of Addiction Medicine 1:4, pages 180-185.
Crossref
Crossref
. (2007) Mortality after Release from Prison. New England Journal of Medicine 356:17, pages 1785-1787.
Crossref
Crossref
P. Christensen. (2007) Commentary: Extreme cause-specific mortality in a cohort of adult prisoners--1988 to 2002: a data-linkage study. International Journal of Epidemiology 36:2, pages 317-318.
Crossref
Crossref
DEBORAH ZADOR. (2007) Methadone maintenance: making it better. Addiction 102:3, pages 350-351.
Crossref
Crossref
Matthew Hickman, Sandra Carrivick, Susan Paterson, Neil Hunt, Deborah Zador, Linda Cusick & John Henry. (2006) London audit of drug‐related overdose deaths: characteristics and typology, and implications for prevention and monitoring. Addiction 102:2, pages 317-323.
Crossref
Crossref
Thomas Kerr, Nadia Fairbairn, Mark Tyndall, David Marsh, Kathy Li, Julio Montaner & Evan Wood. (2007) Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug and Alcohol Dependence 87:1, pages 39-45.
Crossref
Crossref
Karl A. Sporer & Alex H. Kral. (2007) Prescription Naloxone: A Novel Approach to Heroin Overdose Prevention. Annals of Emergency Medicine 49:2, pages 172-177.
Crossref
Crossref
George A Kenna, Darci M Nielsen, Patricia Mello, Alison Schiesl & Robert M Swift. (2007) Pharmacotherapy of Dual Substance Abuse and Dependence. CNS Drugs 21:3, pages 213-237.
Crossref
Crossref
Michael Soyka, Sabine M. Apelt, Martin Lieb & Hans-Ulrich Wittchen. (2006) One-year Mortality Rates of Patients Receiving Methadone and Buprenorphine Maintenance Therapy. Journal of Clinical Psychopharmacology 26:6, pages 657-660.
Crossref
Crossref
MARK STOOVÉ. (2006)
MORTALITY IN A COHORT OF OPIATE AND AMPHETAMINE USERS IN PERTH, WESTERN AUSTRALIA: COMMENT ON BARTU
ET AL.
(2006)
. Addiction 101:10, pages 1523-1524.
Crossref
Crossref
Joan Trujols, Ivan Solà, Ioseba Iraurgi & José Pérez de los Cobos. (2006) Contextualizing Methadone-Related Deaths: Failure to Contextualize May Be Considered a Weapon Against Public Health. Therapeutic Drug Monitoring 28:5, pages 712-713.
Crossref
Crossref
Gabriele Fischer & Beate Kayer. (2006) Substanzabhängigkeit vom Morphintyp – State-of-the-Art der Erhaltungstherapie mit synthetischen OpioidenOpioid dependence: State-of-the-art treatment. Psychiatrie und Psychotherapie 2:2, pages 39-54.
Crossref
Crossref
Steven W. Villafranca, John D. McKellar, Jodie A. Trafton & Keith Humphreys. (2006) Predictors of retention in methadone programs: A signal detection analysis. Drug and Alcohol Dependence 83:3, pages 218-224.
Crossref
Crossref
Peer Brehm Christensen, Eva Hammerby, Else Smith & Shelia M. Bird. (2006) Mortality among Danish drug users released from prison. International Journal of Prisoner Health 2:1, pages 13-19.
Crossref
Crossref
Jürgen Rehm, Ulrich Frick, Christina Hartwig, Felix Gutzwiller, Patrick Gschwend & Ambros Uchtenhagen. (2005) Mortality in heroin-assisted treatment in Switzerland 1994–2000. Drug and Alcohol Dependence 79:2, pages 137-143.
Crossref
Crossref
Maarten Merkx & Gerard Alderliefste. (2010) Medische behandeling van opiaatafhankelijkheid met methadon: Doseren onder Toezicht. Verslaving 1:1, pages 11-18.
Crossref
Crossref
Jane Carlisle Maxwell, Thomas W. Pullum & Karen Tannert. (2005) Deaths of clients in methadone treatment in Texas: 1994–2002. Drug and Alcohol Dependence 78:1, pages 73-81.
Crossref
Crossref
Nina Shah, Sarah L. Lathrop & Michael G. Landen. (2005) Unintentional methadone‐related overdose death in New Mexico (USA) and implications for surveillance, 1998–2002. Addiction 100:2, pages 176-188.
Crossref
Crossref
Joanne Neale & Michele Robertson. (2005) Recent life problems and non‐fatal overdose among heroin users entering treatment. Addiction 100:2, pages 168-175.
Crossref
Crossref
John M. Corkery, Fabrizio Schifano, A. Hamid Ghodse & Adenekan Oyefeso. (2004) The effects of methadone and its role in fatalities. Human Psychopharmacology: Clinical and Experimental 19:8, pages 565-576.
Crossref
Crossref
Thomas Kerr, Alex Wodak, Richard Elliott, Julio S Montaner & Evan Wood. (2004) Opioid substitution and HIV/AIDS treatment and prevention. The Lancet 364:9449, pages 1918-1919.
Crossref
Crossref
I. G. SHEERIN, F. T. GREEN & J. D. SELLMAN. (2009) What is the cost‐effectiveness of hepatitis C treatment for injecting drug users on methadone maintenance in New Zealand?. Drug and Alcohol Review 23:3, pages 261-272.
Crossref
Crossref
W. K. Bryant, S. Galea, M. Tracy, T. Markham Piper, K. J. Tardiff & D. Vlahov. (2004) Overdose deaths attributed to methadone and heroin in New York City, 1990–1998. Addiction 99:7, pages 846-854.
Crossref
Crossref
Wayne Hall. (2004) The contribution of research to Australian policy responses to heroin dependence 1990–2001: a personal retrospection*. Addiction 99:5, pages 560-569.
Crossref
Crossref
Karl A Sporer. (2004) Buprenorphine. Annals of Emergency Medicine 43:5, pages 580-584.
Crossref
Crossref
E. Digiusto, A. Shakeshaft, A. Ritter, S. O'Brien & R. P. Mattick. (2004) Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addiction 99:4, pages 450-460.
Crossref
Crossref
Carl A Latkin, Wei Hua & Karin Tobin. (2004) Social network correlates of self-reported non-fatal overdose. Drug and Alcohol Dependence 73:1, pages 61-67.
Crossref
Crossref
Joan Trujols & José Pérez de los Cobos. (2004) Morbimortalidad relacionada con el uso de metadona: necesidad de su contextualización. Medicina Clínica 122:3, pages 116-117.
Crossref
Crossref
. (2003) Erratum. Addiction 98:9, pages 1325-1326.
Crossref
Crossref
Ludwig Kraus, Rita Augustin, Martin Frischer, Petra Kümmler, Alfred Uhl & Lucas Wiessing. (2003) Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction 98:4, pages 471-485.
Crossref
Crossref
Matthew Hickman, Peter Madden, John Henry, Allan Baker, Chris Wallace, Jon Wakefield, Gerry Stimson & Paul Elliott. (2003) Trends in drug overdose deaths in England and Wales 1993–98: methadone does not kill more people than heroin. Addiction 98:4, pages 419-425.
Crossref
Crossref
. (2003) Office-Based Treatment of Opioid-Dependent Patients. New England Journal of Medicine 348:1, pages 81-82.
Crossref
Crossref
M. Auriacombe, J.-P. Daulouède & J. Tignol. (2003) Experiencia con buprenorfina en Francia. Trastornos Adictivos 5:4, pages 309-319.
Crossref
Crossref
JOHN R. M. CAPLEHORN & OLAF H. DRUMMER. (2009) Methadone dose and post‐mortem blood concentration. Drug and Alcohol Review 21:4, pages 329-333.
Crossref
Crossref
P. N. Gueye, B. Megarbane, S. W. Borron, F. Adnet, M. Galliot‐Guilley, I. Ricordel, J. Tourneau, D. Goldgran‐Toledano & F. J. Baud. (2002) Trends in opiate and opioid poisonings in addicts in north‐east Paris and suburbs, 1995–99. Addiction 97:10, pages 1295-1304.
Crossref
Crossref
Elizabeth Ernst, Anne Bartu, Aurora Popescu, Kenneth F. Ilett, Robert Hansson & Noel Plumley. (2002) Methadone‐related deaths in Western Australia 1993–99. Australian and New Zealand Journal of Public Health 26:4, pages 364-370.
Crossref
Crossref
Dr Andrew Byrne. (2002) Commentary. Australian and New Zealand Journal of Public Health 26:4, pages 362-363.
Crossref
Crossref
John R.M. Caplehorn & Olaf H. Drummer. (2002) Fatal methadone toxicity: signs and circumstances, and the role of benzodiazepines. Australian and New Zealand Journal of Public Health 26:4, pages 358-362.
Crossref
Crossref
Kim Wolff. (2002) Characterization of Methadone Overdose: Clinical Considerations and the Scientific Evidence. Therapeutic Drug Monitoring 24:4, pages 457-470.
Crossref
Crossref
Marcel C. A. Buster, Giel H. A. van Brussel & Wim van den Brink. (2002) An increase in overdose mortality during the first 2 weeks after entering or re‐entering methadone treatment in Amsterdam. Addiction 97:8, pages 993-1001.
Crossref
Crossref
John Corkery. (2002) The relationship between notifications to the Home Office Addicts Index and deaths of notified addicts. Drugs and Alcohol Today 2:2, pages 31-38.
Crossref
Crossref
I. Markez alonso, I. Iraurgi castillo & M. Póo ruiz. (2002) Programas de mantenimiento con metadona en el País Vasco: dispositivos específicos y oficinas de farmacia. Trastornos Adictivos 4:3, pages 171-180.
Crossref
Crossref
. (2001) Predictors of accidental fatal drug overdose among a cohort of injection drug users. American Journal of Public Health 91:6, pages 984-987.
Crossref
Crossref
Aimee L. McRae, Kathleen T. Brady & Susan C. Sonne. (2001) ALCOHOL AND SUBSTANCE ABUSE. Medical Clinics of North America 85:3, pages 779-801.
Crossref
Crossref
John B Saunders & Alun H Richards. (2000) Getting to grips with heroin and other opioid use. Medical Journal of Australia 173:10, pages 509-510.
Crossref
Crossref
A Heinemann, S Iwersen-Bergmann, S Stein, A Schmoldt & K Püschel. (2000) Methadone-related fatalities in Hamburg 1990–1999: implications for quality standards in maintenance treatment?. Forensic Science International 113:1-3, pages 449-455.
Crossref
Crossref
Frank Sporkert & Fritz Pragst. (2000) Determination of methadone and its metabolites EDDP and EMDP in human hair by headspace solid-phase microextraction and gas chromatography–mass spectrometry. Journal of Chromatography B: Biomedical Sciences and Applications 746:2, pages 255-264.
Crossref
Crossref
DAVID BEST, MICHAEL GOSSOP, LAN‐HO MAN, EMILY FINCH, JUDY GREENWOOD & JOHN STRANG. (2009) Accidental and deliberate overdose among opiate addicts in methadone maintenance treatment: are deliberate overdoses systematically different?. Drug and Alcohol Review 19:2, pages 213-216.
Crossref
Crossref
ANDREW BYRNE. (2009) Nine‐year follow‐up of 86 consecutive patients treated with methadone in general practice, Sydney, Australia. Drug and Alcohol Review 19:2, pages 153-158.
Crossref
Crossref
Joanne Neale. (2000) Methadone, methadone treatment and non-fatal overdose. Drug and Alcohol Dependence 58:1-2, pages 117-124.
Crossref
Crossref
James Bell & Deborah Zador. (2000) A Risk-Benefit Analysis of Methadone Maintenance Treatment. Drug Safety 22:3, pages 179-190.
Crossref
Crossref
John R M Caplehorn & Olaf H Drummer. (1999) Mortality associated with New South Wales methadone programs. Medical Journal of Australia 171:8, pages 442-442.
Crossref
Crossref
RALF GERLACH & JOHN R.M. CAPLEHORN. (2009) Attitudes and beliefs of doctors prescribing methadone to addicts in the Westfalen‐Lippe region of Germany. Drug and Alcohol Review 18:2, pages 163-170.
Crossref
Crossref
Joanne Neale. (1999) Drug users’ views of substitute prescribing conditions. International Journal of Drug Policy 10:3, pages 247-258.
Crossref
Crossref
John RM Caplehorn & Olaf H Drummer. (1999) Mortality associated with New South Wales methadone programs in 1994: lives lost and saved. Medical Journal of Australia 170:3, pages 104-109.
Crossref
Crossref
Annie Mino, Arnaud Bousquet & Barbara Broers. (1999) Substance Abuse and Drug-Related Death, Suicidal Ideation, and Suicide: A Review. Crisis 20:1, pages 28-35.
Crossref
Crossref
David A Zanis & George E Woody. (1998) One-year mortality rates following methadone treatment discharge. Drug and Alcohol Dependence 52:3, pages 257-260.
Crossref
Crossref
Daniela D’Ippoliti, Marina Davoli, Carlo A Perucci, Fulvia Pasqualini & Anna Maria Bargagli. (1998) Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage. Drug and Alcohol Dependence 52:2, pages 167-171.
Crossref
Crossref
John R.M Caplehorn, Thomas S Lumley & Les Irwig. (1998) Staff attitudes and retention of patients in methadone maintenance programs. Drug and Alcohol Dependence 52:1, pages 57-61.
Crossref
Crossref
John R.M. Caplehorn, Thomas S. Lumley, Les Irwig & John B. Saunders. (1998) Changing attitudes and beliefs of staff working in methadone maintenance programs. Australian and New Zealand Journal of Public Health 22:4, pages 505-508.
Crossref
Crossref
Sandra Sunjic & Deborah Zador. (1997) Methadone‐related deaths in New South Wales. Medical Journal of Australia 167:3, pages 174-174.
Crossref
Crossref
Karen Miotto, Michael J. McCann, Richard A. Rawson, Dominick Frosch & Walter Ling. (1997) Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts. Drug and Alcohol Dependence 45:1-2, pages 131-134.
Crossref
Crossref
Katja Troberg, Martin Bråbäck, Pernilla Isendahl, Suzan Nilsson, Disa Dahlman & Anders Håkansson. (2022) Malmö Treatment Referral and Intervention Study (MATRIS)—36-Month Follow-Up on Retention and Substance Use Among Patients Referred from a Needle Exchange Program to Opioid Substitution Treatment. SSRN Electronic Journal.
Crossref
Crossref